Vebreltinib for Advanced or Metastatic CCS

Clinical trial NCT07153887 · RECRUITING

Trial details

NCT number: NCT07153887
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Sarcoma (CCS)

Start date: 2025-09-30
Primary completion: 2026-07-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.